| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/24/2009 | US20090238837 High Affinity Siglec Ligands |
| 09/24/2009 | US20090238834 Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer |
| 09/24/2009 | US20090238829 Stabilized single domain antibodies |
| 09/24/2009 | US20090238826 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 09/24/2009 | US20090238824 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/24/2009 | US20090238819 Therapeutic and diagnostic agents |
| 09/24/2009 | US20090238763 High penetration compositions and uses thereof |
| 09/24/2009 | US20090238757 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
| 09/24/2009 | US20090238755 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 09/24/2009 | DE102008013623A1 Pharmazeutische Zusammensetzung zur Diagnose oder Behandlung von Zinkfinger Protein assoziierten Erkrankungen A pharmaceutical composition for diagnosis or treatment of diseases associated zinc finger protein |
| 09/24/2009 | CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 09/24/2009 | CA2719134A1 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | CA2718949A1 Peptide compositions for cancer treatment |
| 09/24/2009 | CA2718936A1 Novel heterocyclic compounds and uses therof |
| 09/24/2009 | CA2718884A1 Heat shock protein gp96 vaccination and methods of using same |
| 09/24/2009 | CA2718872A1 Novel tyrosine kinase inhibitors |
| 09/24/2009 | CA2718685A1 (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases |
| 09/24/2009 | CA2718558A1 Midazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as_melanocortin-4 receptor modulators |
| 09/24/2009 | CA2718123A1 Quinazoline derivatives as raf kinase modulators and methods of use thereof |
| 09/24/2009 | CA2718076A1 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts |
| 09/24/2009 | CA2717954A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 09/24/2009 | CA2717071A1 Methods of treatment using anti-mif antibodies |
| 09/24/2009 | CA2716856A1 Aurora kinase modulators and method of use |
| 09/24/2009 | CA2716592A1 Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
| 09/24/2009 | CA2712705A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/24/2009 | CA2710811A1 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 09/23/2009 | EP2103689A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/23/2009 | EP2103628A1 Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same |
| 09/23/2009 | EP2103624A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/23/2009 | EP2103620A1 Fused heterocyclic compound |
| 09/23/2009 | EP2103619A1 Imidazothiazole derivatives |
| 09/23/2009 | EP2103618A1 Novel ansamitocin derivatives |
| 09/23/2009 | EP2103614A1 Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| 09/23/2009 | EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same |
| 09/23/2009 | EP2102392A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity |
| 09/23/2009 | EP2102331A1 Anti-tumor vaccine derived from normal chemically modified cells |
| 09/23/2009 | EP2102242A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 09/23/2009 | EP2102234A2 Polypeptides comprising intracytoplasmic death domain and nkg2d ligand domain |
| 09/23/2009 | EP2102229A1 Pyrrolydine derivatives as iap inhibitors |
| 09/23/2009 | EP2102212A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 09/23/2009 | EP2102211A2 Heterobicyclic metalloprotease inhibitors |
| 09/23/2009 | EP2102190A1 Compounds and compositions as kinase inhibitors |
| 09/23/2009 | EP2102175A1 Triazole derivative as an hsp 90 inhibitor |
| 09/23/2009 | EP2102173A1 Pyrimidyl derivatives as protein kinase inhibitors |
| 09/23/2009 | EP2102158A1 Prodrugs of diphenyl ox- indol- 2 -one compounds for the treatment of cancers |
| 09/23/2009 | EP2101877A2 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 09/23/2009 | EP2101814A1 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof |
| 09/23/2009 | EP2101812A1 Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |
| 09/23/2009 | EP2101807A2 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 09/23/2009 | EP2101805A2 Specific therapy and medicament using integrin ligands for treating cancer |
| 09/23/2009 | EP2101790A1 Combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent |
| 09/23/2009 | EP2101782A2 Use of mtki 1 for treating or preventing bone cancer |
| 09/23/2009 | EP2101759A1 Methods of using mek inhibitors |
| 09/23/2009 | EP2101758A2 Steroid sulphatase inhibitors for treating hormone dependent cancer |
| 09/23/2009 | EP2101755A2 Polyalkyloxydibenz (c,e) oxepine derivatives as medicaments |
| 09/23/2009 | EP2101731A2 Endoxifen methods and compositions |
| 09/23/2009 | EP1706428B1 Anti-cancer antibodies with reduced complement fixation |
| 09/23/2009 | EP1699797B1 Pyrrolotriazine compounds as kinase inhibitors |
| 09/23/2009 | EP1682548B1 Pyridopyrimidinones for the treatment of cancer diseases |
| 09/23/2009 | EP1606406B1 SHORT INTERFERING RNA (siRNA) ANALOGUES |
| 09/23/2009 | EP1581557B1 Metastin derivatives and their use |
| 09/23/2009 | EP1509229B1 Compositions comprising hepoxilin analogs and their use in the treatment of cancer |
| 09/23/2009 | EP1482928B1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP1448508B1 Double esters |
| 09/23/2009 | EP1086138B1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 09/23/2009 | EP1073734B1 Tumor associated nucleic acids and uses therefor |
| 09/23/2009 | CN101538572A Recombinant lactic acid bacteria containing recombinant alpha-2b interferon and application thereof |
| 09/23/2009 | CN101538556A Method for replicating adenovirus by way of selection and mutual compensation |
| 09/23/2009 | CN101538554A Survivability-screened cancer stem cells, preparation method, application and kit as well as antigen composite thereof, preparation method, application and kit |
| 09/23/2009 | CN101538537A Pestalotiopsis fici and discovery and application of generated anti-tumor active compounds thereof |
| 09/23/2009 | CN101538520A Tricholoma matsutake wine |
| 09/23/2009 | CN101538331A Single chain antibody-lidamycin fusion protein ER (Fv-LDP) targeting EGFR |
| 09/23/2009 | CN101538315A Method for preparing Leuprorelin by combination of solid phase method and liquid phase method |
| 09/23/2009 | CN101538313A Peptide-based compounds |
| 09/23/2009 | CN101538312A Preparation and applications of RGD-fatty amine series compound as tumor targeting vector material |
| 09/23/2009 | CN101538311A Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof |
| 09/23/2009 | CN101538309A Method for extracting ursolic acid from persimmon leaf by composite countercurrent method |
| 09/23/2009 | CN101538305A Method for preparing composite with antineoplastic activity by panoxadiol |
| 09/23/2009 | CN101538304A Fungi mixture and method for preparing same |
| 09/23/2009 | CN101538303A Natural fatty acid monoester derivatives of cucurbitacin monomers |
| 09/23/2009 | CN101538302A 16alpha-methyl-3-hydroxyl-19-norpregnane-1, 3, 5-triene-20-ketone and preparation method thereof |
| 09/23/2009 | CN101538293A Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 09/23/2009 | CN101538272A Phenyl propanoid derivative, preparation method thereof and application thereof to preparation of medicines resisting breast cancer |
| 09/23/2009 | CN101538262A Bryoanthrathiophenic substance and synthetic method thereof |
| 09/23/2009 | CN101538259A Crystal form A of zedoary root cyclic diolefine, preparation method thereof and application thereof in preparing anti-tumor drugs |
| 09/23/2009 | CN101538258A New composition of salvia miltiorrhiza and derivative, preparation method and medicine application thereof |
| 09/23/2009 | CN101538256A 3, 4-diaryl furan-2, 5-diketone derivative and 3, 4-substitute-diaryl-1 H-pyrrole-2, 5-diketone derivative and application thereof |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538247A Alkaloid compound and preparation method thereof |
| 09/23/2009 | CN101538245A One-class pyridazinone compounds and preparation method and application thereof |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101538239A Antitumor antibiotic and preparation method thereof |
| 09/23/2009 | CN101538234A Beta-elemene indican derivative and synthetic method thereof |
| 09/23/2009 | CN101537190A Peptide-based compounds |
| 09/23/2009 | CN101537189A Aptamer and new use of derivative thereof |
| 09/23/2009 | CN101537185A Tumor cell actively targeted drug delivery system, preparation method and application thereof |
| 09/23/2009 | CN101537184A Composition containing water-insoluble high-activity drug and preparation method thereof |
| 09/23/2009 | CN101537165A Chinese traditional medicine preparation for curing colon cancer |
| 09/23/2009 | CN101537157A Chinese medicine for treating esophagus cancer |